Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Synta Pharma begins phase I trial of STA-9090/docetaxel combination

Aug. 25, 2010

FDA grants fast track status to ThermoDox for HCC

Aug. 25, 2010

New hepatocyte growth factor receptor inhibitors claimed by sanofi-aventis

Aug. 25, 2010

KPT-127 inhibits tumor growth in vivo in xenograft model

Aug. 25, 2010

FDA grants orphan drug status for brain cancer product 2B3-101

Aug. 24, 2010

Sunitinib/erlotinib improves progression-free survival in NSCLC

Aug. 24, 2010

Banyu Pharma and Merck & Co. present new PKB inhibitors

Aug. 24, 2010

Health Canada conditionally approves Tasigna for CML

Aug. 24, 2010

Meta-analysis reveals potential link between ARBs and onset of cancer

Aug. 23, 2010

University of Pittsburgh receives NCI grant to develop agents for head and neck cancer

Aug. 20, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...